reported that increased expression of Nrf-2 in gliomas, coupled with decreased expression of Keap1, significantly accelerates cell proliferation, promotes tumor formation, and impedes programmed cell death (51) (Figure 11). Here, NFE2L2 is linked to central nervous system cancer.